Background Cystatin C is a low‐molecular‐weight protein that is freely filtered by the
glomerulus and catabolized after reabsorption by the proximal tubular cells in healthy …

OBJECTIVE: Urinary cystatin C has been reported to be a good marker for tubular damage
and acute kidney injury. The aim of this study was to develop a high throughput assay for the …

Objective. The goal with this study was to evaluate the analytical performance of a new
cystatin C immunoassay (Tina-quant® a Cystatin C, Roche Diagnostics GmbH). The …

BACKGROUND We evaluated the analytical performance of 4 cystatin C assays (Siemens N
Latex on BNII, Roche Tina-quant on Cobas c501, Genzyme on Cobas c501, and Tosoh ST …

Background: Urinary excretion of the low molecular weight protein cystatin C is a marker of
renal disorders and a good predictor of the severity of acute tubular necrosis. We evaluated …

Aim: There is no commercially available urinary cystatin-C (u-CYSC) test in the market.
Therefore, we optimized and validated an automated immune turbidimetric test for u-CYSC …

Urinary Cystatin C (uCysC) is one of the best biomarkers for the diagnosis of early acute
kidney injury (AKI). Nowadays, particle-enhanced nephelometric immunoassay (PENIA) and …

BACKGROUND Cystatin C is a low molecular weight cysteine proteinase inhibitor whose
plasma or serum concentrations have been shown to be better correlated with glomerular …

BACKGROUND: Human cystatin C is a low molecular weight protein that has been
proposed as a new endogenous marker of glomerular filtration rate. We investigated the …

Objective. To evaluate the performance of the Roche Diagnostics Tina-quant Cystatin C
particle enhanced immuno turbidimetric assay for the measurement of plasma and serum …